HOYA Vision Care Shines a Light on the Latest Evidence and Advances in Myopia Management at SOE 2023

Prague, Czech Republic – 28 June 2023 – HOYA Vision Care, a leader in optical technology innovation, was delighted to be a Silver Sponsor of the European Society of Ophthalmology Congress (SOE 2023) that took place 15–17 June 2023 in Prague, Czech Republic. This year’s SOE 2023 hosted a multi-specialty in-person meeting, delivering a world class scientific programme, offering symposia, workshops, live surgery, debates, mystery cases and updates on all topics.


As part of its commitment to share scientific knowledge and professional insights, and provide innovative solutions to address the growing problem of myopia progression in children, HOYA Vision Care hosted a symposium, Lighting the way: new evidence and advances in myopia management, where leading experts discussed the role of light exposure in myopia, announced the new additions to the MiYOSMART portfolio – MiYOSMART sun spectacle lenses and shared the latest results on the role of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in combination treatment in myopia management.


With growing interest and evidence about the protective effects of outdoor time and daylight on myopia development and its progression in children, both in the ophthalmology practice and in scientific literature,1–5 Professor Behar-Cohen, Professor at Cochin Hospital, Paris Descartes University, France, focused her talk on the researched benefits and risks associated with light exposure on myopic eyes, further highlighting the physical and biological role of light in vision.  


Dr. Andrea Lembo, from the University Hospital San Giuseppe Multimedica in Milan, Italy, discussed the effect of the combination treatment of DIMS spectacle lenses and atropine on Caucasian eyes. Dr Lembo shared his practical experience by presenting the results of an observational, non-randomized study conducted in Italy, which included 146 young patients aged between 6 and 18 years with myopia progression. There were three treatment groups within the study — 0.01% low dose atropine once a day alone, MiYOSMART spectacle lenses alone and a combination treatment with both 0.01% low dose atropine and MiYOSMART spectacle lenses –revealed a reduction in myopia progression, taking into account spherical equivalent refraction and axial elongation, as well as the subjective worsening of visual acuity.6


Dr. Natalia Vlasak, Global Head of Medical and Scientific Affairs at HOYA Vision Care, explained the DI.M.S. Technology behind the MiYOSMART spectacle lens and presented the findings of the six-year follow-up clinical study, the longest clinical study conducted on a myopia management spectacle lens. Further, the launch of the new MiYOSMART sun solution were presented MiYOSMART Chameleon, photochromic spectacle lenses; and MiYOSMART Sunbird, polarized spectacle lenses – currently rolling out in 30 countries worldwide. These two new products provide protection from intense sunlight, while simultaneously slowing down myopia progression using the same D.I.M.S. Technology used in MiYOSMART clear spectacle lenses7–13 shown to slow myopia progression on average by 60% in children aged 8 to 13.14


Since its launch in 2018 until the end of 2022, over 4 million MiYOSMART spectacle lenses have been purchased by parents across the world.15 With the launch of the new MiYOSMART Chameleon and MiYOSMART Sunbird spectacle lenses, HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world. 

“Together, we can tackle myopia in children”


About HOYA Vision Care

As a global leader in optical technology, HOYA Vision Care is dedicated to providing innovative vision care solutions for every stage of a patient’s life. A steadfast partner to Eye Care Professionals around the world, it stands at the forefront of optical excellence. With a global presence, consisting of 43 laboratories and a growing team of 20,000 employees, HOYA Vision Care delivers innovative lenses and other vision care solutions to millions of people in 110 countries.

About HOYA Vision Care

For further information contact:

HOYA Vision Care PR

Susan Brown


Follow HOYA Vision Care on Linkedin


Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of Myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.



  1. 1. Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.
  2. 2. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.
  3. 3. Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017;95(6):551-566.
  4. 4. Dhakal R, Shah R, Huntjens B, et al. Time spent outdoors as an intervention for myopia prevention and control in children: an overview of systematic reviews. Ophthalmic Physiol Opt. 2022;42(3):545-558.
  5. 5. Karthikeyan SK, Ashwini DL, Priyanka M, et al. Physical activity, time spent outdoors, and near work in relation to myopia prevalence, incidence, and progression: An overview of systematic reviews and meta-analyses. Indian J Ophthalmol. 2022;70(3):728-739.
  6. 6. Nucci P, Lembo A, Schiavetti I, et al. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLoS One. 2023 Feb 16;18(2):e0281816.
  7. 7. HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and polarized lenses. 02/2023. Tests were conducted at room temperature (23°C).
  8. 8. HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022.
  9. 9. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
  10. 10. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
  11. 11. Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484. Available at: https://iovs.arvojournals.org/article.aspx?articleid=2560920 (Last accessed 01/06/2023).
  12. 12. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus-statement/ (Last accessed 01/06/2023).
  13. 13. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis Sci. 2006;47(13):1225.
  14. 14. Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368.
  15. 15. Based on the number of MiYOSMART lenses sold as per Hoya sales data on file as of December 2022.